(Q38326729)

2 September 2017

1 reference

title

Diagnosis of monoclonal gammopathy of renal significance (English)

1 reference

monoclonal gammopathy of renal significance

2 September 2017

main subject

0 references

author

Giampaolo Merlini

10

1 reference

2 September 2017

13

1 reference

2 September 2017

Murielle Roussel

11

0 references

Efstathios Kastritis

object named as

Efstathios Kastritis

9

0 references

Nelson Leung

object named as

Nelson Leung

2

0 references

Robert A Kyle

14

object named as

Robert A Kyle

1 reference

2 September 2017

1

Frank Bridoux

1 reference

2 September 2017

5

Sanjeev Sethi

1 reference

2 September 2017

6

Jean-Paul Fermand

1 reference

2 September 2017

7

Maria M Picken

1 reference

2 September 2017

12

Fernando C Fervenza

1 reference

2 September 2017

Colin A Hutchison

3

1 reference

2 September 2017

Guy Touchard

4

1 reference

2 September 2017

Guillermo A Herrera

8

1 reference

2 September 2017

Samih H Nasr

15

1 reference

2 September 2017

International Kidney and Monoclonal Gammopathy Research Group

16

1 reference

2 September 2017

language of work or name

English

0 references

publication date

21 January 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

87

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

698-711

1 reference

Nephrotoxic potential of Bence Jones proteins.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Renal failure in multiple myeloma. Pathogenesis and prognostic implications

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Pathology of the kidney in Waldenström's macroglobulinemia. Study of sixteen cases.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Dangerous small B-cell clones.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Renal Monoclonal Immunoglobulin Deposition Disease: A Report of 64 Patients from a Single Institution

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

How I treat monoclonal gammopathy of renal significance (MGRS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Long-term outcome of autologous stem cell transplantation in light chain deposition disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Outcome in Renal AL Amyloidosis After Chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Long-term outcome of renal transplantation in light-chain deposition disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Proliferative Glomerulonephritis with Monoclonal IgG Deposits Recurs in the Allograft

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Renal Transplantation in Systemic Amyloidosis-Importance of Amyloid Fibril Type and Precursor Protein Abundance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Proliferative glomerulonephritis with monoclonal IgG deposits.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Systemic light chain amyloidosis: an update for treating physicians

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

The incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Fanconi's syndrome induced by a monoclonal Vkappa3 light chain in Waldenstrom's macroglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Screening panels for detection of monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

NCCN clinical practice guidelines in oncology: multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

ELISAs for free human immunoglobulin light chains in serum: improvement of assay specificity by using two specific antibodies in a sandwich detection method

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

N Latex FLC - new monoclonal high-performance assays for the determination of free light chain kappa and lambda

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Membranoproliferative glomerulonephritis: the role for laser microdissection and mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Modern approaches to the treatment of amyloidosis: the critical importance of early detection in surgical pathology

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Optical properties of amyloid stained by Congo red: history and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Renal amyloidosis. Correlations between morphology, chemical types of amyloid protein and clinical features

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Ultrastructural immunolabeling in the diagnosis of monoclonal light-and heavy-chain-related renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Fibrillary glomerulonephritis: a report of 66 cases from a single institution.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Immunotactoid glomerulopathy: clinicopathologic and proteomic study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Dysproteinemia, proteinuria, and glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Renal involvement in monoclonal (type I) cryoglobulinemia: two cases associated with IgG3 kappa cryoglobulin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Light chain crystal deposition as a manifestation of plasma cell dyscrasias: the role of immunoelectron microscopy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Plasma cell dyscrasia causing light chain tubulopathy without Fanconi syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Light chain tubulopathy without Fanconi syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Dysproteinemia-related nephropathy associated with crystal-storing histiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Proliferative glomerulonephritis with monoclonal IgM deposits without Waldenström's macroglobulinemia: case report and review of the literature.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

A proliferative glomerulonephritis secondary to a monoclonal IgA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Single light chain subclass (kappa chain) immunoglobulin deposition in glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

C3 glomerulopathy: consensus report

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Dense Deposit Disease Associated With Monoclonal Gammopathy of Undetermined Significance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

C3 glomerulonephritis associated with monoclonal gammopathy: a case series.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Monoclonal gammopathy-associated proliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Prevalence of monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.408

7 January 2021

Identifiers

DOI

10.1038/KI.2014.408

1 reference

Dimensions Publication ID

2 September 2017

1017561260

0 references

1 reference